There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
To evaluate the pharmacologic activity and tolerability of JSM6427, a potent and first
selective small-molecule inhibitor of integrin alpha5beta1, in monkey and rabbit models
of choroidal neovascularization (CNV).